Publicaciones en colaboración con investigadores/as de Hospital Universitari Sant Joan de Reus (18)

2023

  1. Real life data: follow-up assessment on Spanish Gaucher disease patients treated with eliglustat. TRAZELGA project

    Orphanet Journal of Rare Diseases, Vol. 18, Núm. 1

2022

  1. Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE)

    Autoimmunity Reviews, Vol. 21, Núm. 10

2021

  1. The incidence rate of pulmonary arterial hypertension and scleroderma renal crisis in systemic sclerosis patients with digital ulcers on endothelin antagonist receptors (ERAs) and phosphodiesterase-5 inhibitors (PDE5i)

    Rheumatology (Oxford, England), Vol. 60, Núm. 2, pp. 872-880

2020

  1. Current functioning of cardio-oncology units in Spain

    Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1418-1422

  2. Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype

    Atherosclerosis, Vol. 292, pp. 42-51

2019

  1. Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

    Aging, Vol. 11, Núm. 9, pp. 2874-2888

  2. Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  3. The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin

    Frontiers in Oncology, Vol. 9, Núm. MAR

2018

  1. A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study

    Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704

2017

  1. Cardio-Onco-Hematology in Clinical Practice. Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 70, Núm. 6, pp. 474-486

2016

  1. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients

    American Journal of Gastroenterology, Vol. 111, Núm. 10, pp. 1456-1465

2013

  1. Diagnóstico y tratamiento del dolor irruptivo oncológico: Recomendaciones de consenso

    Revista de la Sociedad Espanola del Dolor, Vol. 20, Núm. 2, pp. 61-68

2012

  1. Impact of empirical treatment in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. bacteremia. A multicentric cohort study

    BMC Infectious Diseases, Vol. 12

  2. La adición de leche fermentada suplementada con esteroles vegetales mejora el cumplimiento de los cambios en el estilo de vida en los pacientes hipercolesterolémicos. Estudio RECIPE

    Clinica e Investigacion en Arteriosclerosis, Vol. 24, Núm. 4, pp. 173-180

2011

  1. Severe 2009 A/H1N1v influenza in pregnant women in Spain

    Critical Care Medicine

2009

  1. Sustained ventricular arrhythmias in unstable angina patients: Results of the ARIAM database

    Medical Science Monitor, Vol. 15, Núm. 6

2006

  1. Bloqueo auriculoventricular en la angina inestable. Resultados del registro ARIAM

    Medicina Intensiva, Vol. 30, Núm. 9, pp. 432-439

2002

  1. Heterozygous familial hypercholesterolemia in Spain. Description of 819 non related cases

    Medicina Clinica, Vol. 118, Núm. 13, pp. 487-492